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Summary
RfaH is a bacterial elongation factor that increases
expressionofdistalgenesinseverallong,horizontally
acquired operons. RfaH is recruited to the transcrip-
tion complex during RNA chain elongation through
speciﬁc interactions with a DNA element called ops.
Following recruitment, RfaH remains bound to RNA
polymerase (RNAP) and acts as an antiterminator by
reducing RNAP pausing and termination at some
factor-independent and Rho-dependent signals. RfaH
consistsoftwodomainsconnectedbyaﬂexiblelinker.
The N-terminal RfaH domain (RfaHN) recognizes the
ops element, binds to the RNAP and reduces pausing
and termination in vitro. Functional analysis of single
substitutions in this domain reported here suggests
that three separate RfaHN regions mediate these func-
tions. We propose that a polar patch on one side of
RfaHN interacts with the non-template DNA strand
duringrecruitment,whereasahydrophobicsurfaceon
the opposite side of RfaHN remains bound to the b
subunit clamp helices domain throughout transcrip-
tionoftheentireoperon.Thethirdregionisapparently
dispensable for RfaH binding to the transcription
complex but is required for the antitermination modi-
ﬁcation of RNAP.
Introduction
RfaH is an operon-speciﬁc paralogue of the widely con-
served general elongation factor NusG. NusG is essential
in wild-type Escherichia coli (Sullivan and Gottesman,
1992) and is associated with RNAP transcribing most of
the E. coli MG1655 genes (Mooney et al., 2009a). Recent
studies (Cardinale et al., 2008) demonstrate that NusG
becomes dispensable when the rac prophage kil gene
is deleted and suggest that NusG limits transcription of
the horizontally transferred DNA by enhancing Rho-
dependent termination (Sullivan and Gottesman, 1992;
Burns and Richardson, 1995). Additionally, E. coli NusG
cooperates with NusA, NusB, NusE and other factors to
form specialized anti-termination complexes that are
resistant to pause and termination signals (Zhou et al.,
2002; Torres et al., 2004).
By contrast, RfaH appears to act independently of other
proteins and targets only those operons that have a 12 nt
ops (operon polarity suppressor) element in their untrans-
lated leader regions (Belogurov et al., 2009). The ops
element is required for RfaH recruitment to RNAP (Bailey
et al., 1997; Artsimovitch and Landick, 2002; Belogurov
et al., 2009); it mediates sequence-speciﬁc binding of
RfaH to the non-template (NT) DNA strand exposed on
the surface of the transcription elongation complex (TEC)
and may induce TEC isomerization into a distinct state
necessary for recruitment of RfaH. Our recent analysis
identiﬁed several ops-containing operons that are
enriched for RfaH (Belogurov et al., 2009) in MG1655;
these operons are devoid of NusG and do not encode
essential functions. Consistently, RfaH is dispensable for
growth of the commensal E. coli (Farewell et al., 1991).
However, RfaH activates expression of several virulence
and ﬁtness genes, such as LPS (Wandersman and
Letoffe, 1993), capsule (Stevens et al., 1994; Rahn and
Whitﬁeld, 2003) and haemolysin (Bailey et al., 1992;
Leeds and Welch, 1996) biosynthesis genes, and is
essential for virulence (Nagy et al., 2002; 2006).
RfaH and NusG increase the transcript elongation rate
and suppress RNAP pausing at backtracked sites in vitro
(Artsimovitch and Landick, 2000; 2002). However, some
of their effects are different even in a puriﬁed system:
for example, RfaH also reduces pausing at hairpin-
dependent sites, whereas NusG does not. Most impor-
tantly, NusG increases, whereas RfaH reduces Rho-
dependent termination (Artsimovitch and Landick, 2002;
Mooney et al., 2009b); this difference underlies the
opposite regulatory functions of RfaH and NusG in the
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© 2010 Blackwell Publishing Ltdcell. RfaH inhibits Rho action and thus activates expres-
sion of laterally acquired genes (Belogurov et al., 2009),
whereas NusG appears to act in concert with Rho to
inhibit expression of foreign genes (Cardinale et al.,
2008).
These opposite functions may be partially explained by
different architectures of the two proteins (Fig. 1). Both
proteins consist of two domains connected by a ﬂexible
linker (Belogurov et al., 2007). The N-terminal domains
(RfaHN and NusGN) are structurally similar and mediate
RNAP binding and anti-pausing (AP) activities of both
proteins (Belogurov et al., 2007; Mooney et al., 2009b).
The C-terminal domains are drastically different (Fig. 1A
and C): a short a-helical hairpin in RfaH, a b-barrel Tudor
domain in NusG. Strikingly, the RfaHC sequence can be
computationally ﬁtted into a NusGC-like structure (Bel-
ogurov et al., 2009). The two domains are tightly associ-
ated in a free RfaH, and the interdomain interface masks
a hydrophobic surface on RfaHN that is thought to serve
as an RNAP binding site; we have proposed that RfaH
binding to an ops element triggers the domain separation
and allows RfaH binding to the RNAP (Belogurov et al.,
2007). In contrast, the two NusG domains do not interact,
implying that the RNAP-binding surface on NusGN is
always accessible (Mooney et al., 2009b); indeed, NusG
associates with most transcribed operons (Mooney et al.,
2009a).
In a model of RfaH bound to the TEC, one side of RfaHN
binds to the exposed segment of the NT stand and the
other to the tip of the b′ clamp helices (CH) domain,
whereas the RfaHC domain does not make any contacts
to RNAP or DNA (Fig. 1B). This model is supported by
(i) zero-length UV-cross-linking of RfaH to the NT DNA
(Artsimovitch and Landick, 2002); (ii) the ability of RfaHN
to compete with s70 for binding to the b′ CH during elon-
gation (Sevostyanova et al., 2008); (iii) the loss of ops
binding conferred by substitutions of adjacent basic resi-
dues in RfaH (see Results); (iv) the deleterious effects of
Fig. 1. The structural context of the RfaH
action.
A. The E. coli RfaH model (Belogurov et al.,
2007) with RfaH
N shown in grey and the
RfaH
C – in cyan. The aromatic residues at the
domain interface (orange) and the polar
residues on the opposite side of the RfaH
N
domain (blue) are shown as sticks.
B. A model of RfaH bound to the TEC. The
T. thermophilus RNAP (Vassylyev et al., 2002)
is shown as green lines with the bridge helix
(b′ BH) highlighted in magenta, the template
DNA – in red, the NT DNA – in blue, the
nascent RNA – in yellow. Position of the
RNAP active site is marked by the
high-affinity catalytic Mg
2+ ion (a small
magenta sphere). RfaH
N (grey) is bound to
the NT DNA strand and to b′ CH, whereas
RfaH
C (cyan) makes no contacts to RNAP.
C. The E. coli NusG model (Steiner et al.,
2002) is shown for comparison, the
structurally distinct NusG
C domain is shown
in dark red.
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the b′ CH on RfaH association with the TEC (Belogurov
et al., 2007; Sevostyanova et al., 2008).
Here, we show that RfaHN also supports anti-
termination at Rho-dependent and intrinsic terminators in
vitro. Taken together with our previous reports that RfaHN
is sufficient for the AP activity and s70 exclusion in vitro
(Svetlov et al., 2007; Sevostyanova et al., 2008), these
data indicate that RfaHN contains all the elements
required for RfaH function. In this work, we set out to
dissect these elements. We constructed a set of single
residue substitutions in RfaHN and tested their pheno-
types in vitro. We report that the two previously hypoth-
esized ops-binding and RNAP-binding regions (Fig. 1A)
are indeed required for RfaH recruitment to the TEC.
Unexpectedly, our analysis also identiﬁed a third RfaHN
cluster, which is apparently dispensable for binding to
the TEC but is essential for the AP activity of RfaH.
Results
RfaHN mediates all transcriptional activities of
RfaH in vitro
We reported that RfaHN is sufficient for the AP activity
of RfaH at factor-independent pause signals (Belogurov
et al., 2007) and at s-dependent pause sites (Sevosty-
anova et al., 2008). Similarly, Mooney et al. (2009b)
have found that NusGN is sufficient for NusG’s effects on
RNA chain elongation. However, NusGN does not
support increased Rho-dependent termination. Thus, we
wanted to test whether RfaHN alone can mediate the
effects of full-length RfaH on Rho-dependent termina-
tion. RfaHN, which possesses an extensive hydrophobic
surface that is masked either by RfaHC (in a free RfaH)
or by the b′ CH (when bound to the TEC), is insoluble
when overexpressed separately. To circumvent this
problem, we introduced a TEV protease cleavage site
into the interdomain linker of the C-terminally His-tagged
RfaH, cleaved the puriﬁed full-length protein using the
His-tagged TEV protease, and removed both the pro-
tease and the RfaHC domain by absorption to the
Ni-Sepharose resin. Thus, isolated RfaHN is poorly
soluble and prone to aggregation but, when present at
low concentration, acts similarly to the full-length RfaH
(Belogurov et al., 2007).
We tested the effect of RfaHN at the intrinsic (factor-
independent) Thly terminator, which has been shown to
respond to RfaH in vivo (Koronakis et al., 1988) and
in vitro (Carter et al., 2004). During single-round in vitro
transcription in the absence of RfaH, ~40% of transcripts
were terminated at Thly (Fig. 2), whereas addition of RfaH
decreased termination efficiency more than twofold,
to 18%; the same effect has been reported previously
(Carter et al., 2004). Consistent with its key role in modi-
ﬁcation of RNAP into a pause-resistant state, the isolated
RfaHN domain had the same effect on termination at Thly
(18%). An apparent reduction in an overall level of RNA
synthesis observed in the presence of RfaH or RfaHN
is due to the RNAP arrest at the ops site under these
conditions (not visible on the gel) and does not affect
data interpretation: those RNAP molecules that do reach
the termination site bypass it more efficiently than in the
absence of RfaH.
To assay RfaHN effect on Rho-mediated RNA release,
we used a template that encodes the opsP followed by a
well-characterized phage ltR1 Rho-dependent termination
signal [Fig. 3A, pIA267 (Artsimovitch and Landick, 2002)].
On this template, RfaH and NusG had opposite effects on
Rho-dependent RNA release: consistent with its synergy
with Rho, NusG shifted the distribution of RNA species
towards shorter transcripts, whereas RfaH favoured
synthesis of longer RNAs (Fig. 3B), possibly by reducing
RNAP pausing, and thus Rho-mediated termination. The
RfaHN domain displayed the same effect but was able to
act at lower concentrations; the enhanced activity of RfaHN
was also observed in pause assays (Belogurov et al.,
2007) and may be due to the higher stability of RfaHN/TEC
complex. We conclude that the isolated RfaHN domain is
sufficient for all documented in vitro activities of RfaH.
Fig. 2. RfaH
N effects on intrinsic termination. Transcript generated
on a linear pIA416 DNA template; transcription start site (+1), the
ops element (boxed), Thly terminator structure, terminated and
run-off RNA products are shown on top. Halted
[a-
32P]-CMP-labelled G37 TECs were formed at 60 nM with E. coli
RNAP and challenged with NTPs (10 mM UTP, 200 mM ATP, CTP,
GTP) and rifapentin at 25 mgm l
-1 in the absence or in the presence
of full-length RfaH or RfaH
N. The reactions were incubated for
15 min at 37°C, quenched, and analysed on a 6% denaturing gel
along with the [g-
32P]-ATP-labelled pBR322 MspI digest as a
molecular weight standard (the sizes of fragments are indicated.
Termination efficiency (219-nt long RNA as a fraction of total RNA)
was determined in three independent experiments.
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RfaH has several distinct effects in an in vitro transcrip-
tion assay: it delays RNAP escape from the ops signal,
reduces pausing at hairpin-dependent (class I) pause
sites and inhibits backtracking at class II sites (Artsimov-
itch and Landick, 2002; Svetlov et al., 2007). To simulta-
neously assay the ops recognition and the AP activity of
RfaH, we utilized a pIA349 template that encodes the
tandem ops and his pause signals downstream from a
T7A1 promoter (Fig. 4A). The initial transcribed region
was designed to allow for the formation of radiolabelled
TECs stalled after incorporation of a G residue at position
37 (G37) when transcription is initiated in the absence of
UTP (Fig. 4A). Upon addition of all four NTP substrates
and rifapentin (to block re-initiation), RNAP elongated the
nascent RNA at a characteristic rate, pausing at opsP1,
opsP2 and hisP sites (Fig. 4B).
Here,weusethehairpin-dependenthisPsignaltoevalu-
ate theAP activity of RfaH and its variants. The hisP signal
is the best characterized model system for the analysis of
pausing by the E. coli RNAP; the molecular mechanism of
hairpin-induced pausing (Toulokhonov et al., 2007) and its
response to various regulatory factors, including RfaH
(Artsimovitch and Landick, 2000; 2002) have been char-
acterized.Thewild-type(WT)RfaHreducedpausingatthe
hisP site (position U145 in the pIA349 transcript; the red
line in Fig. 4C), as well as other pause sites.
To evaluate the DNA-binding activity of RfaH variants,
we measured RfaH-induced retention of RNAP at the ops
Fig. 3. RfaH
N effects on Rho-dependent termination.
A. Transcript generated on a linear pIA267 DNA template;
transcription start site (+1), ops, Rho-dependent RNA release sites
and transcript end are indicated.
B. Halted, [a-
32P]-GMP-labelled TECs were formed at 40 nM with E.
coli RNAP. Rho, NusG, RfaH or RfaH
N were added at indicated con-
centrations, followed by addition of NTPs and rifapentin. The reac-
tions were incubated for 15 min at 37°C, quenched, and analysed on
a 6% denaturing gel. A representative gel and four selected traces
for Rho alone (gray), full-length RfaH at 300 nM (red), RfaH
N at
60 nM (blue) and NusG at 40 nM (green) are shown.
Fig. 4. Effects of RfaH on transcription
elongation in vitro.
A. A schematic representation of a linear
template pIA349 with the ops element, the
start site (+1), transcript end (run-off), the
pause sites that occur after the addition U43
(opsP1), C45 (opsP2) and U145 nucleotides
(the hisP pause), and the hisT terminator
indicated.
B. WT RfaH accelerates TEC escape from the
U43 and the hisP sites but delays the RNAP
escape from the C45 site in a single-round
elongation assay. Halted radiolabelled G37
TECs (see Experimental procedures) were
pre-incubated with RfaH at 50 nM or storage
buffer for 5 min at 37°C, and then challenged
with rifapentin at 100 mgm l
-1 and NTPs
(10 mM GTP, 150 mM ATP, CTP, UTP).
Aliquots were withdrawn at times ranging from
5 to 1200 s and analysed on a 8% denaturing
gel.
C. The fractions of RNA at the hisP (red
squares), at or beyond the hisP site (blue
circles), and at the opsP site
(U43 + G44 + C45; green triangles) were
quantiﬁed from the gel in (B) and used to
kinetically model the pauses in the absence
(top) and in the presence (bottom) of the WT
RfaH.
Anti-pausing determinants in RfaH 289
© 2010 Blackwell Publishing Ltd, Molecular Microbiology, 76, 286–301signal. RfaH binds with high affinity (with Kd in a low nM
range) to the TEC paused at the conserved opsP1 site
(Artsimovitch and Landick, 2002), which corresponds to
position U43 in pIA349 transcript (Fig. 4A). During in vitro
transcription (Fig. 4B), the WT RfaH delayed a small frac-
tion of RNAP (~15–20%) two nucleotides downstream of
opsP1 (e.g. opsP2 site, position C45). The escape kinet-
ics from the ops region (positions U43, G44 and C45,
shown by the green line in Fig. 4C) became biphasic. The
initial slope (largely attributed to opsP1) was the same as
in the absence of RfaH (Fig. 4C, top). In contrast, the
second, slower escape phase (attributed to opsP2)w a s
only observed in the presence of RfaH. We argued that
this delay is likely due to contacts of RfaH with the NT
DNA that must be broken to allow RNAP escape from the
opsP site (Artsimovitch and Landick, 2002).
Importantly, RfaH binds DNA only in the context of the
ops-paused TEC; RfaH affinity for an ops DNAoligonucle-
otide is ~1000 times lower than for the TEC. Modelling
suggests that DNA must be deformed to allow for produc-
tive contacts with RfaH (Svetlov et al., 2007); thus, both a
speciﬁc conformation of the NT DNAon the RNAP surface
and RfaH interactions with the RNAP surface residues
may contribute to its increased affinity for the TEC. We
cannot separately determine RfaH affinities for the
ops DNA and RNAP by a conventional binding assay.
Because RfaH remains stably bound to the TEC for the
duration of the transcription cycle (Belogurov et al., 2009),
and therefore likely retains contacts with RNAP and non-
speciﬁc interactions with DNA, we attribute the RNAP
delay at opsP2 primarily to the sequence-speciﬁc interac-
tions between RfaH and the ops element, and use this
delay as an indirect assay to evaluate the strength of
interactions between RfaH and the NT DNA.
Experiments performed in the presence of GreB
(Fig. S1) suggest that RNAP paused at opsP2 is back-
tracked by two nucleotides, so that the active site is
located at the opsP1 site. RfaH therefore likely maintains
speciﬁc contacts with the NT DNA while RNAP moves at
least two nucleotides downstream. Structural and bio-
chemical analyses suggest that the NT DNA segment
exposed on the surface of the elongating RNAP is short
(4–5 nucleotides) and constant at most sites and in TECs
from diverse organisms (Korzheva et al., 2000; Ketten-
berger et al., 2004; Vassylyev et al., 2007); however, no
TEC structure with the transcription bubble intact is avail-
able, and thus the actual path of the single-stranded NT
DNA on RNAP remains unknown. Based on structural
modelling (Belogurov et al., 2007), we proposed that four
ops nucleotides at the upstream edge of the bubble may
be involved in direct contacts with RfaH detected by
cross-linking (Artsimovitch and Landick, 2002). RNAP
translocation by two nucleotides following RfaH recruit-
ment would occlude the RfaH binding site on the NT DNA
unless moderate accumulation, or ‘scrunching’
(Cheetham and Steitz, 1999), of the DNA occurs within
the transcription bubble (Fig. S1). The hypothetical
scrunched state can be resolved either by breakage of the
RfaH/NT DNA contacts or by reannealing of scrunched
DNA. The latter scenario is phenotypically indistinguish-
able from backtracking to the recruitment site as observed
on the pIA349 template (Fig. S1). The RfaH-induced
delay is only observed when the third nucleotide down-
stream from opsP1 is G and the GTP concentration is
low (data not shown), indicating that this effect has little
relevance to RfaH function in vivo.
The main goal of this work is to identify the RfaH deter-
minants that mediate its recruitment to the TEC and the
consequent AP modiﬁcation of RNAP. We focused on
mutational analysis of RfaHN, since it is responsible for all
the direct effects of RfaH on transcript elongation and
termination. We targeted both the surface-exposed resi-
dues that are highly conserved in the NusG-RfaH super-
family (e.g. a subset of hydrophobic residues that may
contact the b′ CH) and those residues that are divergent
between RfaH and NusG (e.g. the positively charged resi-
dues that may constitute the DNA binding site in RfaH).
Below, we summarize the properties of selected single
substitutions in RfaH at the opsP2 and hisP sites.
Substitutions that compromise RfaH-induced
pausing at ops
In our analysis, we treated three consecutive positions
within the opsP site (U43, G44 and C45) as a single
pause site (See Supporting information). In the absence
of RfaH, the majority of RNAP molecules occupied the
opsP1 site (U43) and escaped following a monoexponen-
tial function with a rate constant of ~0.1 s-1. In the pres-
ence of WT RfaH, the U43 site became depopulated and
the RNAP occupancy at G44 and C45 positions was
increased; a slowly escaping fraction (~17%, rate con-
stant 0.003 s-1) emerged at C45, necessitating the use of
a biexponential function for an accurate ﬁt of escape
kinetics.
The effects of various RfaH substitutions on RNAP
delay at C45 are summarized in Fig. 5. K10F and R73D
variants were strongly defective at opsP: RNAP displayed
monoexponential escape kinetics and the pausing pattern
was indistinguishable from that observed in the absence
of RfaH. Thus, these variants are absent from Fig. 5A.
Several variants retained partial activity: they delayed
8–40% of RNAP molecules at C45. Five substitutions
(T72A, K10A, H20A, R73A and R16A) led to strong
defects; the escape rate constant increased three- to
ninefold, whereas the fraction of delayed RNAP was
similar or reduced relative to the WT RfaH. These
residues form a tight cluster (Fig. 5B) that we propose
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and Arg-73 side-chains face the protein exterior and may
make direct contact with the DNA. In contrast, Thr-72
faces the interior and therefore likely affects DNA binding
indirectly, e.g. by controlling the position of Arg-73.
H65A, T66A, Q13A, R23A and T68A variants
appeared mildly defective in NT DNA binding: the RNAP
escape rate constant was increased 1.5- to 2-fold and
the fraction of delayed RNAP was similar or decreased
as compared with WT RfaH. Gln-13 and Arg-23 are
adjacent to the residues forming a putative DNA-binding
cluster and may either directly interact with DNA or
affect positioning of the primary DNA-binding residues.
On the other hand, we hypothesize that the effects of
H65A, T66A and T68A substitutions are indirect and may
result from compromised RfaH interactions with RNAP
(see Discussion).
Three substitutions (E19A, R43A and E48A) were more
effective than WT RfaH: they reduced the escape rate
constant two- to threefold and increased the fraction of
C45-delayed RNAP by ~30%. The apparent stabilization
of the RfaH-DNA contacts by E19A substitution may be
due to the removal of the negatively charged Glu side-
chain from the vicinity of the DNA-binding residues.
Glu-48 may interact with the invariantArg-178 from RfaHC
in free RfaH and with the b′ CH residues in the RfaH–TEC
complex. Changes in both the interdomain and intermo-
lecular contacts upon E48A substitution may contribute to
the observed effect, because escape of at least some
RNAP from the backtracked state at C45 may involve
Fig. 5. Effects of RfaH
N substitutions on pausing at the ops site.
A. Effects of altered RfaH proteins on pause efficiency at (top) and escape rate from (bottom) the C45 position (Fig. 4). See text for details.
B. Substitutions are shown on the RfaH
N structure as sticks and coloured according to their phenotypes (colour coded as in A). The position of
a hypothetical DNA-binding region is indicated.
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stitution at the tip of a b-loop is difficult to interpret; this
loop is predicted to be highly mobile even in RfaH that is
not bound to RNAP (Fig. S2). The b-loop may be involved
in interactions with the b′ CH or with the DNA fork junction
and thus contribute to the RfaH ability to reduce back-
tracking (Svetlov et al., 2007). In E. coli NusG, the size but
not the sequence of this ‘mini-domain’ is important for
activity (Richardson and Richardson, 2005).
Finally, we placed Y54F and F56L into a separate group
since these variants delayed as much as 35–40% RNAP
at C45 and were thus clearly distinct from the WT and all
other variants. Tyr-54 is one of the most conserved resi-
dues in NusG and all of its paralogues; in contrast, Phe-56
is only conserved in RfaH-like proteins, whereas most
NusGs have a Leu at this position (Belogurov et al.,
2009). The two substitutions also had different effects on
escape rate, similar to WT for F56L and four times greater
in the case of Y54F. Both Tyr-54 and Phe-56 are located
on the RfaHN surface thought to constitute the b′ CH
binding site (Belogurov et al., 2007). It is possible that
their substitutions cause RfaH to bind RNAP in an aber-
rant way that increases the backtracking propensity of
the RfaH–TEC complex at C45. The F56L protein, which
mimics the NusG conﬁguration, has a ‘wild-type’ effect on
RNAP escape, implying that it remains tightly bound to the
TEC. In contrast, the more facile RNAP escape from C45
observed in the presence of Y54F suggests that the
altered protein readily dissociates from the backtracked
complex, thereby allowing the TEC to translocate forward
and resume elongation.
Substitutions that compromise the AP activity of RfaHN
After RfaH is recruited to RNAP at the ops site, it remains
bound to the enzyme for thousands of nucleotide addition
cycles (Belogurov et al., 2009), preventing NusG binding,
inhibitingbacktrackingandreducingefficiencyandlongev-
ity of all known types of pauses. Pausing at the hisP site
is traditionally analysed by ﬁtting the decay part of the
pausing curve to a monoexponential function. This analy-
sis outputs well-deﬁned escape rate and pause efficiency
(extrapolated to zero time) parameters but serves as a
rough approximation of the actual events. Indeed, in our
assays RNAP was starting to arrive at hisP only after
5–10 s and continued to simultaneously arrive and escape
for tens or even hundreds of seconds. In addition, different
RfaH mutants produced different proportions of fast and
slow (opsP2 delayed) fractions of RNAP and also gener-
atedvariousdegreesofasynchronyinRNAParrivaltohisP
site. We thus employed a more complex kinetic model that
accounts for the concurrent arrival and escape of both the
fastandtheslowfractionsofRNAPathisP(seeSupporting
information). Our analysis demonstrates that only the ratio
of escape rate constant and efficiency (khisP/EffhisP), but
not the individual parameters, can be accurately deter-
mined for all datasets. This limitation is inherent in the
experimental set-up (concurrent arrival and escape at
hisPwithsimilarrateconstants)andisnotduetoexcessive
complexity of the model. We therefore used khisP/EffhisP as
a measure of AP activity of RfaH variants (Fig. 6).
Q13A, F51A, E19A, H94A, T68A, Q2A, Q24A, K37A,
R23A and H20A variants displayed khisP/EffhisP ratio indis-
tinguishable from that of the WT RfaH within the margin of
error, suggesting that the altered residues are not essen-
tial for TEC binding and AP activity. In contrast, H65A,
F56L, R16A, R73A, W4F, T67A, K42A and T66A variants
displayed khisP/EffhisP ratio similar to that observed with
NusG and two- to threefold lower than that observed with
the WT RfaH. K10F, Y54F and R73D were strongly defec-
tive: they did not elevate khisP/EffhisP ratio above that
observed in the absence of added elongation factors.
Finally, Y8F, K10A, V63D, N70A, E48A, T72A, Y5F, A71N
and R43A variants displayed mild defects, with khisP/EffhisP
ratio in the range of 80–60% of the WT RfaH value. We
note that mildly defective variants cannot be unambigu-
ously differentiated from the WT group due to a continuum
in decreasing khisP/EffhisP values. The substitutions produc-
ing mild phenotypes are usually adjacent to those causing
strong defects (Fig. 6B), suggesting that both types of
substitutions interfere, directly or indirectly, with the same
interaction in the RfaH–TEC complex.
We then focused on pinpointing the causes of dimin-
ished AP activity in strongly defective variants. The
diminished activity may arise from (i) inefficient recruit-
ment at opsP, (ii) dissociation of RfaH prior to arrival to
hisP, or (iii) failure of the TEC-bound RfaH to reduce
pausing. At concentrations above 2 mM, RfaH does not
require opsP for function in vitro, implying that RfaH can
be recruited to RNAP non-speciﬁcally (data not shown).
Thus, both the inefficient recruitment and the subse-
quent dissociation should be compensated by increasing
the concentration of the RfaH variant. Indeed, at 3 mM,
F56L, R73A and K42A displayed khisP/EffhisP ratios indis-
tinguishable from that observed in the presence of WT
RfaH (Fig. 6A, inset), whereas partial compensation (a
1.5-fold increase in khisP/EffhisP ratio) was observed with
R16A and W4F. These results suggest that defects in
recruitment to, or retention on, the TEC were the primary
causes of diminished AP activity for W4F, R16A, K42A,
F56L and R73A variants.
In contrast, the low khisP/EffhisP ratios of H65A, T67A
and T66A were not markedly affected by a 60-fold
increase in concentration, suggesting that these substi-
tutions eliminated AP activity. This is supported by the
observation that H65A, T67A and T66A variants remain
tightly associated with the TEC (A. Sevostyanova et al.,
manuscript in preparation). Finally, increasing Y54F
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AP activity, but the khisP/EffhisP ratio remained threefold
below that of WT RfaH and equal to that of NusG. We
conclude that the Y54F change not only compromises
RfaH retention on the TEC, but likely also completely
abolishes RfaH–TEC interactions essential for its AP
activity at the hisP (which NusG lacks).
To assess the impact of substitutions on the RfaH struc-
ture, we ﬁrst utilized a CONCOORD-PBSA molecular
mechanics approach (Benedix et al., 2009). The predicted
effects of most substitutions on stability and overall
structure were small (DDG  2 kcal mol-1 and root mean
square values < 2 Å relative to WT RfaH; Table S2), and
did not correlate with a given mutant’s AP activity,
although variants with an increased stability tended to
have increased or near-WT levels of activity. Alignment of
the structural ensembles for each variant and the starting
RfaH structure (PDB ID 2OUG) demonstrated that pre-
dicted changes in ﬂexibility were insigniﬁcant in the case
of the closed conformation, the state for which structural
information exists (Figs S2 and S3). This suggests that
the detrimental effects of substitutions analysed in this
work are not mediated by gross changes in the RfaH
structure or folding.
Fig. 6. Effects of RfaH
N substitutions on pausing at the hisP site.
A. Effects of altered RfaH proteins on pausing at hisP at 50 nM protein (Fig. 4). Inset; the AP activity measured at 3 mM RfaH.
B. Substitutions are shown on the RfaH
N structure as sticks and coloured according to their phenotypes (colour coded as in A). The positions
of a presumed b′ CH binding site and an HTT motif are indicated, together with that of the hypothetical DNA-binding region (Fig. 5B).
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we carried out CD analysis of selected RfaH variants
(Fig. S4). This analysis revealed no gross structural
alterations conferred by substitutions. In particular, the
spectrum for the Y54F protein, which displays dramatic
defects both in vitro (Figs 5 and 6) and in vivo (see the
next section), was indistinguishable from that of WT
RfaH.
In vivo effects of RfaHN substitutions
We wished to test whether the RfaH residues implicated
by our in vitro assays are functionally important in the
cell. We designed an assay system (Fig. 7A) consisting
of three components. First, we constructed an rfaH -
strain by a targeted disruption of the rfaH gene in E. coli
DH5a strain (see Experimental procedures). Second, we
constructed a compatible low-copy-number plasmid
(pIA957) with the rfaH gene cloned under the control of
aP trc promoter and a lacIQ1 variant, which contains pro-
moter mutations that increase the expression of lac
repressor (Muller-hill et al., 1968). We also made vectors
lacking rfaH (pIA947) or containing substitutions in RfaH.
Third, we constructed a reporter that carries a Photo-
rhabdus luminescens (Winson et al., 1998) luxCDABE
operon under control of the PBAD promoter/araC cassette
(Guzman et al., 1995) and the ops site (pGB83) and a
control plasmid without the ops element (pGB63). This is
a medium-copy-number plasmid and, since all natural
RfaH targets are transcribed at very low levels, we did
not use arabinose induction in our assays.
The lux operon encodes the luciferase (luxA and luxB)
genes that oxidize FMN-H2 and a long-chain aliphatic
aldehyde in the presence of O2 to yield a luminescence
signal. The aldehyde is subsequently regenerated by a
multi-enzyme reductase complex encoded by the luxC,
luxD and luxE genes. The lux system is a sensitive (over
at least ﬁve orders of magnitude) and simple bioreporter
capable of autonomous light emission: it encodes all
the components required to generate the bioluminescent
signal, which is then directly measured in the cell culture.
In the absence of RfaH, expression of the lux operon
was very low whether or not the ops element was present
on the plasmid (0.3 and 1.2 units; Fig. 7B). In the pres-
ence of the episomally expressed WT RfaH, the reporter
activity increased more than 700-fold when the ops + tem-
plate was used, and ~20-fold with the control plasmid that
lacks the ops. Thus, the observed activity was critically
dependent on RfaH and was greatly enhanced by the ops
element. Although the absence of ops did not completely
eliminate the RfaH effect, the reporter activity was greatly
reduced (from 217 to 26 units, approximately eightfold
effect). The residual, ops-independent effect of RfaH
could be due to (i) the ability of RfaH to bind to the TEC at
other sites or (ii) the presence of an ops-like element
somewhere on the reporter plasmid. Indeed, sequence
analysis revealed an ops-like element in the luxC
gene (GGCGGTAGAGca, marked as ops* in Fig. 7A, left).
However, we found that substitutions in luxC that compro-
mise the ops function in vitro did not alter either the lux
reporter activity or its response to RfaH (unpublished).
Interestingly, the RfaH effect in vivo is dramatically greater
than its effect measured at any single site in vitro, consis-
tent with the idea that RfaH effect is cumulative over many
consecutive sites within the transcription unit and may
include post-transcriptional events, such as recruitment
of the translational machinery (Artsimovitch and Landick,
2002).
We next tested whether the isolated RfaHN domain
would function when expressed at a low level in vivo;
overexpression of RfaHN leads to its sequestration in the
inclusion bodies. In agreement with our in vitro analysis
(Belogurov et al., 2007), RfaHN was ~1.5-fold more active
than the WT protein and acted largely independently of
ops; the inclusion of the ops element increased the RfaHN
activity only 1.3-fold.
The seven RfaH variants that displayed defects in vitro
were also defective in lux operon expression; their activi-
ties ranged from 1% to ~50% of the WT activity, and were
increased 4- to 15-fold in the presence of ops (Fig. 7B).
The most defective variant, Y54F, did not increase lux
expression above background, consistent with its inability
to reduce pausing at the hisP site (Fig. 6A). R73D,
another strongly defective variant, displayed ~20% of the
WT activity and the strongest dependence on ops (a
15-fold difference), consistent with its pronounced defects
in ops-binding and AP properties in the puriﬁed system. A
somewhat higher activity of R73D as compared with Y54F
could be due to a partial compensation of R73D defects
at elevated RfaH concentration; R73A but not Y54F was
rescued at 3 mM RfaH in vitro (Fig. 6). K10A, H20A and
T66A variants retained ~30–35% of the WT activity,
whereas the mildly defective in vitro T72A and F51A vari-
ants were only approximately twofold less active than the
WT RfaH.
Although the in vitro and in vivo phenotypes of the
tested RfaH variants did not match perfectly, we did
observe a correlation between their in vitroAP activity and
the in vivo effects on lux expression. The observed differ-
ences are likely due in part to the nature of signals, which
RfaH acts upon to increase the expression of the lux
operon: while the hairpin-dependent hisP is an excellent
model to study the mechanism of AP, most pause sites
present on natural templates are short-lived pauses that
control the overall rate of transcription and serve as
precursors to termination. In addition, the presence of
other cellular elongation factors or ongoing translation
may affect RfaH function.
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not merely a result of their reduced expression or stability,
we measured the cellular level of these proteins by
Western analysis with polyclonal anti-RfaH antibodies
(Belogurov et al., 2009). These antibodies recognize
epitopes within the RfaHC domain (A. Sevostyanova,
unpubl. obs.) and thus their binding should be unaffected
by substitutions in RfaHN. We found that all variants
Fig. 7. The in vivo reporter assay for the
RfaH activity.
A. The assay system. We constructed an rfaH
knockout strain and two plasmids to assay
the effects of ops and RfaH variants in vivo.
The ﬁrst plasmid (pGB83; left) has a ColE1
origin of replication and contains the entire
Photorhabdus luminescens (Winson et al.,
1998) luxCDABE operon under the control of
the AraC-controlled PBAD promoter and an ops
element. The second compatible (P15A ori)
plasmid (right; pIA957) has the E. coli rfaH
gene cloned under the Ptrc control; the
plasmid also carries an engineered lacI
Q1
gene.
B. Analysis of the effects of selected RfaH
substitutions on lux operon expression in the
presence (dark bars) and the absence (light
bars) of the ops element. The results are
expressed as luminescence corrected for the
cell densities of individual cultures divided by
a factor of 1000. The data represent the
average of at least four independent
experiments.
C. Western analysis of cell extracts
expressing RfaH variants (as in panel B;
see Experimental procedures) performed in
parallel with the lux assay with polyclonal
RfaH
C-speciﬁc antibodies.
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the same or a slightly higher level than the WT RfaH
(Fig. 7C), suggesting that their defects are directly con-
ferred by the substitutions; the level of expression of the
isolated RfaHN could not be measured by this assay.
Discussion
RfaH is recruited to the TEC through speciﬁc contacts to
the DNA and RNAP and remains bound to the enzyme
until it completes the synthesis of the entire operon. While
bound, RfaH increases the apparent rate of RNA synthe-
sis on natural templates by suppressing pausing and
reduces termination. In a puriﬁed system, all these acti-
vities are mediated by the N-terminal, RfaHN domain. The
data presented here suggest that RfaHN contains three
regions that mediate DNA recognition, retention on the
RNAP throughout transcription, and AP modiﬁcation.
Below, we present the arguments in support of this
hypothesis.
A cluster of polar and charged residues mediates
RfaHN binding to DNA
Our previous studies indicate that RfaH directly and spe-
ciﬁcally binds to the NT DNA (Artsimovitch and Landick,
2002). Based on molecular modelling, we proposed that a
polar region on RfaHN interacts with ops (Belogurov et al.,
2007) in the RfaH/TEC complex. Importantly, this model
was rather speculative: it was built using the structure of T.
thermophilus RNAP, the only bacterial species for which
high-resolution structures are available, but which differs
from the E. coli enzyme in many surface features that may
be essential for RfaH action. Furthermore, the path of the
NT DNA was not constrained by any experimental data –
none of the TEC structures currently available contains
the NT DNA in the transcription bubble, and it is quite
possible that both the ops sequence and the bound RfaHN
constrain its path on the RNAP surface.
The results of the mutational analysis that we carried
out to evaluate this model (Fig. 5) are consistent with our
predictions. Five residues that form a patch on the RfaHN
side opposite of the interdomain interface (Lys-10,Arg-16,
His-20, Thr-72 and Arg-73) are required for RfaH-induced
delay at ops, which we argue is due to persistent RfaH/
DNA interactions. The effects of substitutions at these
residues are unlikely to result from alterations in the
protein structure (Supporting information); consistently,
their defects were alleviated by increased RfaH concen-
tration (Fig. 6). Importantly, the assay for RfaH/DNA inter-
actions employed here is indirect, and additional lines of
evidence (such as identiﬁcation of rfaH suppressors of
mutations in ops or a high-resolution model of RfaH/ops
contacts) would be required to support this model.
RfaHN does not have any recognizable DNA-binding
motif, which is not surprising given that it binds to a rather
unusual target: the single-stranded DNA strand exposed
on, and interacting with, the surface of RNAP (Wang and
Landick, 1997). The ops element spans 12 nt, among
which 10 are highly conserved; however, the modelling
predicts that only about four ops bases are available for
direct contacts with RfaHN, too few to explain the high
speciﬁcity of RfaH towards its targets observed in vivo
(Belogurov et al., 2009). The remaining ops bases likely
mediate a conformational change in the TEC that is
required for RfaH recruitment.
A hydrophobic surface of the N-terminal domain
mediates its binding to RNAP
The post-recruitment activity of RfaH depends on its per-
sistent contacts to RNAP. We propose that these contacts
are established between a hydrophobic patch on RfaH
and the tip of the b′ CH. We reported that the deletion of
the tip or substitutions of the Ile-290 or Ile-291 residues
eliminated the RfaH ability to enhance elongation
(Belogurov et al., 2007). We also showed that RfaH Y8A
and b′ I290R substitutions decreased the RfaH ability to
compete with s, presumably by destabilizing the RfaH/b′
CH contacts and allowing s to bind to the b′ CH instead
(Sevostyanova et al., 2008). Here we show that substi-
tutions of several residues in this region decrease the
AP activity of RfaH (e.g. W4F and F56L; Fig. 6). The effect
of these substitutions is alleviated by an increase in RfaH
concentration, consistent with the reduced affinity of the
altered proteins. Mutagenesis of E. coli nusG, in vitro
analysis of NusG variants with substitutions of residues in
the homologous patch (Mooney et al., 2009b) and two-
hybrid assays (Nickels, 2009) all suggest that NusG inter-
acts with the b′ CH, supporting our assumption that RfaHN
and NusGN bind to RNAP in a similar fashion (Belogurov
et al., 2009). Although alternative explanations are pos-
sible, we favour a model in which these hydrophobic
residues make direct contacts to the b′ CH.
The HTT motif as an AP module
The common activity of RfaHN and NusGN domains is to
increase the rate of RNA chain elongation. This rate is
limited by sequence-dependent signals that induce forma-
tion of an elemental pause state, in which the 3′ end of the
nascent RNA is misaligned in the active site (Artsimovitch
and Landick, 2000; Sydow et al., 2009); this isomerization
is thought to occur from a pre-translocated state (Tou-
lokhonov et al., 2007). Throughout elongation, RfaH likely
maintains contacts with the DNA at the upstream part
of the transcription bubble, where it would be poised
to promote strand reannealing and thus translocation.
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translocated TEC state and fails to act on pause-free
templates and with pause-resistant RNAPs, suggesting
that it prevents isomerization into the elemental pause
(Svetlov et al., 2007). In the simplest scenario, RfaH inter-
actions with the b′ CH and the NT strand would be suffi-
cient to induce forward translocation, thereby reducing
pausing. In this scenario, RfaH should be able to act as
long as it remains bound to the TEC.
However, our data identify an additional HTT motif
that is apparently required for AP by RfaH, but is distinct
from the proposed DNA- and RNAP-binding motifs. The
defects of substitutions in the HTT motif are not sup-
pressed at high RfaH concentration (Fig. 6), suggesting
that these changes are unlikely to cause the loss of
affinity. In search for an alternative explanation, we
re-examined the RfaH/TEC model (Belogurov et al.,
2007). We found that the HTT motif makes a hypothetical
contact with the b gate loop (b GL, Fig. 8), a conserved
loop that has been proposed to play a key role in the DNA
loading in the course of the promoter complex formation
(Vassylyev et al., 2002).Alarge caveat of this modelling is
that it has been performed with the T. thermophilus RNAP,
in which the b GL sequence is quite distinct from that in
the E. coli RNAP and which is not ‘designed’ to interact
with RfaH, which is absent from many bacteria, including
Thermus. However, if this contact can indeed be estab-
lished in the E. coli TEC, it would offer a plausible hypoth-
esis for the RfaH AP effects: the b GL belongs to a mobile
domain that likely moves in concert with the b′ clamp
during isomerization into a paused state (Toulokhonov
et al., 2007). During pausing and termination, the clamp is
thought to partially open (Artsimovitch and Landick,
2000); RfaH could restrict the mobility of b and b′ parts of
the clamp, thereby preventing its opening. Our recent
data suggest that interactions between RfaH and the b GL
are essential for RfaH function in vivo and in vitro but are
not required for RfaH binding to the TEC (A. Sevosty-
anova et al., manuscript in preparation).
The functions of the RfaH domains
Our previous (Belogurov et al., 2007; Svetlov et al., 2007)
and present (Figs 2 and 3) analyses show that RfaHN acts
in vitro at least as efficiently as the full-length protein.
RfaHN is both necessary and sufficient for binding to
RNAP and to the ops DNA and mediates all the effects on
elongation. However, the isolated RfaHN is poorly soluble
and lacks the key regulatory feature of RfaH, which dis-
tinguishes it from NusG: in contrast to the full-length
protein, RfaHN recruitment to the TEC is independent of
the ops element.
RfaHC has no discernible effects on transcription in vitro
but plays several modulatory roles (Belogurov et al.,
2009). First, RfaHC renders the full-length protein soluble
by masking an extensive hydrophobic surface on
RfaHN, which acts as an RNAP binding site. Second,
RfaHC restricts the RfaH action to a small number of
ops-containing operons by preventing binding to RNAP
except at the ops sites, where RfaHN contacts with the
DNA trigger domain dissociation. Third, RfaHC may be
engaged in cross-talk with the translation and secretion
machineries; the last feature may be particularly important
because RfaH-controlled operons are laterally acquired
(and thus are likely poorly translated) and mediate
synthesis of various extracytoplasmic molecules.
Our studies are in agreement with a recent analysis of
the E. coli NusG domains (Mooney et al., 2009b), which
Fig. 8. The functional contacts between RfaH and the TEC. We
propose that RfaH function depends on three separate contacts
with the NT DNA strand (blue), the b′ CH (orange), and the b GL
(magenta). The side-chains of the RfaH residues that are proposed
to make the key contacts with these elements are shown as
spheres in the matching colours. The ops elements from selected
operons that are associated with RfaH in MG1655 (Belogurov
et al., 2009) are conserved with the exception of the two
highlighted bases. Sequences of the b′ CH and the b GL are highly
and moderately conserved respectively; the residues that differ
from the E. coli (Eco) sequence are shaded in light green. The
abbreviations are: Tth, Thermus thermophilus; Hpy, Helicobacter
pylori; Bsu, Bacillus subtilis; Mtu, Mycobacterium tuberculosis;
Mge, Mycoplasma genitalium.
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in vitro but fails to support the enhancement of Rho-
dependent termination. NusGC interacts with Rho and
other partners: NusG is required for Nun-dependent
termination and for the assembly of l phage and E. coli
rRNA anti-termination complexes. Different NusGC sub-
stitutions eliminate the effect on either Rho- or Nun-
dependent termination, suggesting that these proteins
interact with distinct regions on NusGC (Mooney et al.,
2009b).
RfaH has an opposite (and likely indirect) effect on
Rho-dependent termination and does not interact with
Rho; the most straightforward explanation is that RfaHC
structure is drastically different from that of NusGC (essen-
tially turned inside-out) and the Rho-interacting residues
that are located on the surface of NusGC are inaccessible
in RfaH (Fig. 1). While it is possible that RfaHC may refold
into a b-barrel after recruitment, we argued that substitu-
tions of residues in an RfaH-like protein that contact Rho
in NusG (and whose identity is yet unknown) must have
happened early after the ancestral nusG duplication
to eliminate Rho binding, the key functional difference
between the two paralogues (Belogurov et al., 2009). We
propose that RfaHC may interact with other cellular pro-
teins and may be essential for coupling transcription
of RfaH-controlled operons to translation and ﬁnally
to secretion. In support of this hypothesis, Bailey et al.
(2000) reported that RfaH and ops nucleate the formation
of a high-molecular-weight complex whose assembly
requires RNAP and associated elongation factors, ribo-
somes, and the cytoplasmic membrane fraction.
C-terminal domains in eukaryotic NusG paralogues are
more complex and likely mediate interactions with the
components of the transcriptional and post-transcriptional
complexes. For example, a plant-speciﬁc SPT5-like
protein has a long carboxy-terminal extension that inter-
acts with AGO4 to direct RNA-directed DNA methylation
by polV (Bies-Etheve et al., 2009) and transcriptional
silencing of retrotransposons and repetitive elements.
Experimental procedures
Plasmids and strains
Plasmids used in this work are listed in Table S1. Sequences
of all plasmid constructs were veriﬁed at the OSU PMGF
centre and are available at our lab web site, http://www.
osumicrobiology.org/homepages/artsimovitch/sequences/
pIA_plasmids_list.htm. Disruption of the RfaH open reading
frame (ORF) was carried out in the E. coli DH5a (lDE3)
strain using TargeTron Gene Knockout System (Sigma-
Aldrich, St Louis, MO, USA) according to the manufacturer’s
protocol. Brieﬂy, RfaH ORF sequence was submitted to the
proprietary search engine (http://www.sigma-genosys.com/
targetron/) to identify potential target sites for intron insertion,
and one of the top ranked targets (for intron insertion at
position 21) was selected due to its proximity to the start
codon. Intron insertion plasmid, pACD4K-C, was retargeted
to this site on rfaH using PCR with a set of oligonucleotides
generated according to the TargeTron algorithm. Disruption
of rfaH by the retrohoming intron was induced by addition of
IPTG to the culture transformed with the retargeted plasmid
and application of the kanamycin selection. RfaH disruption
was conﬁrmed by genomic PCR and sequencing, followed by
‘curing’ the strain of the plasmid; the resulting DrfaH strain
was named IA149.
Proteins and reagents
Oligonucleotides were obtained from Integrated DNA Tech-
nologies (Coralville, IA, USA), NTPs and [a-
32P]-NTPs were
from GE Healthcare (Piscataway, NJ, USA), restriction and
modiﬁcation enzymes – from NEB (Ipswich, MA, USA), PCR
reagents – from Roche (Indianapolis, IN, USA), other chemi-
cals – from Sigma (St Louis, MO, USA) and Fisher (Pitts-
burgh, PA, USA). Plasmid DNAs and PCR products were
puriﬁed using spin kits from Qiagen (Valencia, CA, USA) and
Zymo Research (Orange, CA, USA). Rho protein was a gift
from Rachel A. Mooney. The full-length RfaH variants, the
RfaH
N domain and RNAP were puriﬁed as described in
Belogurov et al. (2007).
Halted complex formation
Linear templates for in vitro transcription were generated by
PCR ampliﬁcation. TECs were formed with 40 nM of linear
DNA template and 50 nM RNAP holoenzyme in 20–100 mlo f
transcription buffer (20 mM Tris-chloride, 20 mM NaCl, 2 mM
MgCl2, 14 mM 2-mercaptoethanol, 0.1 mM EDTA, 5% glyc-
erol, pH 7.9). To make the elongation complexes halted after
addition of G37 on pIA349 and pIA416 templates, transcrip-
tion was initiated in the absence of UTP, with ApU at 150 mM,
ATP and GTP at 2.5 mM, CTP at 1 mM, with
32P derived from
[a-
32P]-CTP (3000 Ci mmol
-1). Halted complexes were
formed for 15 min at 37°C and stored on ice prior to use.
Single round pause assays
Halted [
32P]-CTP labelled elongation complexes were pre-
pared in 50 ml of transcription buffer. Elongation factors were
added followed by 3 min incubation at 37°C. Transcription
was restarted by addition of GTP to 15 mM, CTP, ATP and
UTP to 150 mM, and rifapentin to 25 mgm l
-1. Samples were
removed at 10, 20, 40, 60, 90, 120, 180, 300, 600 and 1200 s
and after a ﬁnal 5 min incubation with 200 mM GTP (chase),
and quenched by addition of an equal volume of STOP buffer
(10 M urea, 50 mM EDTA, 45 mM Tris-borate; pH 8.3, 0.1%
bromophenol blue, 0.1% xylene cyanol).
Intrinsic termination assay at Thly
Halted complexes were prepared in 20 ml of transcription
buffer with 25 nM of linear DNA pIA416 template and 60 nM
of RNAP holoenzyme. Full-length RfaH, RfaH
N (or storage
buffer) was added followed by 3 min incubation at 37°C.
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200 mM ATP, CTP, GTP) and rifapentin. Reactions were incu-
bated at 37°C for 15 min and quenched as above.
Rho-dependent termination assays
Halted complexes (A26) were prepared on pIA267 template
in the absence of CTP in 30 ml of Rho buffer (40 mM Tris-HCl,
50 mM KCl, 5 mM MgCl2, 0.1 mM dithiothreitol, 3% glycerol,
pH 7.9) supplemented with ApU at 150 mM, ATP and UTP
at 2.5 mM, GTP at 1 mM, and 5 mCi of [a-
32P]-GTP
(3000 Ci mmol
-1) during 15 min incubation at 37°C. Full-
length RfaH, RfaH
N and NusG (or storage buffer) were added
followed by 3 min incubation at 37°C. Transcription was
restarted by addition of GTP to 15 mM, CTP, ATP and UTP to
150 mM, and rifapentin to 25 mgm l
-1. Reactions were incu-
bated at 37°C for 15 min and stopped as above.
Sample analysis
Samples were heated for 2 min at 90°C and separated by
electrophoresis in denaturing acrylamide (19:1) gels (7 M
Urea, 0.5¥ TBE) of various concentrations (6–10%). RNA
products were visualized and quantiﬁed using a PhosphorIm-
ager Storm 820 System (GE Healthcare), ImageQuant Soft-
ware and Microsoft Excel. Kinetic analysis of pause assays is
described in detail in the Supporting information.
In vivo assays
A promoter-less lux reporter vector, pIA874, in which several
unique restriction sites were engineered by site-directed
mutagenesis, was constructed from pSB417 (Winson et al.,
1998). During these manipulations, we have realized that the
actual sequence of pSB417 differs from the conceptual one,
and thus completely sequenced the redesigned vector. To
create a PBAD–lux fusion pGB063, a fragment containing the
araC gene and the PBAD promoter was PCR ampliﬁed from
pBAD30 (Guzman et al., 1995) and cloned into the NotI and
XhoI sites of pIA874. The ops
+ plasmid pGB083 was con-
structed by cloning a PCR fragment containing the ops
element upstream of rfbB (ampliﬁed from E. coli DH5a
genomic DNA) between the NheI and XhoI sites of pGB063.
To test the RfaH effects in trans, a compatible plasmid
(pIA947) was constructed by cloning a PCR fragment con-
taining the PlacI
Q1-lacI region from pIA249 (the lacI
Q1 variant
was introduced into the primer) between the EagI and HindIII
sites of pACYC184. To construct pIA957, an NdeI-HindIII
fragment bearing wild-type RfaH was excised from pIA432
and cloned between the same sites of pIA947. Altered RfaH
variants were recloned from pIA432-like plasmids listed in
Table S1.
Plasmids carrying RfaH variants were co-transformed with
a lux reporter vector (pGB083) into IA149 strain and plated
on selective media (100 mgm l
-1 carbenicillin, 50 mgm l
-1
chloramphenicol). The single colonies were inoculated into
3 ml of Luria–Bertani (LB) media supplemented with antibiot-
ics and incubated at 37°C with agitation. After 6 h of growth,
cultures were diluted into fresh LB containing antibiotics and
0.1% glucose to an OD600 of ~0.05 and allowed to grow for
additional 6 h. Neither construct required induction (with
IPTG and arabinose) since background expression of rfaH
and lux operon was sufficient to generate the signal; this
approach was chosen to mimic the very low expression levels
of both rfaH and the operons it controls in E. coli (Belogurov
et al., 2009). Luminescence was measured in 200 ml aliquots
in triplicates on FLUOstar OPTIMA plate reader (BMG
LABTECH GmbH, Offenburg, Germany) and normalized by
cell density. Results were analysed using Microsoft Excel.
Western blotting
Derivatives of the DrfaH strain transformed with plasmids
carrying RfaH variants or an empty vector were grown in the
same conditions as for the Lux assay. Cell samples were
collected by centrifugation and resuspended in 1 ml of Lysis
buffer (50 mM Tris-HCl, 500 mM NaCl, 5% glycerol, 0.1 mM
b-ME; pH 7.9) containing 0.1 mg ml
-1 lysozyme. Cells were
sonicated and extracts were cleared by centrifugation.
Extract samples containing 22 mg of protein (as determined
by Bradford assay) were loaded on a 10% SDS Bis-Tris gel
(Invitrogen, Carlsbad, CA, USA). Protein transfer was per-
formed in Tris-Glycine buffer, pH 8.3 containing 20% metha-
nol onto Hybond™ ECL membrane (GE Healthcare,
Piscataway, NJ, USA) at 300 mA for 2 h in a Mini Trans-Blot
Cell (Bio-Rad Laboratories, Hercules, CA, USA). Blocking of
non-speciﬁc sites was carried out overnight at 4°C in PBS-T
buffer (1¥ PBS pH 7.5, 0.2% Tween-20) containing 5% non-
fat dry milk. The membrane was incubated with rabbit poly-
clonal antibodies against RfaH (Belogurov et al., 2009)
diluted 1/4000 in PBS-T for 1 h with agitation at room
temperature. After ﬁve washes with PBS-T, membrane was
incubated with rabbit IgG for 1 h (1/10 000 dilution in PBS-T,
obtained from GE Healthcare), washed again and exposed to
ECL Plus detection reagents (GE Healthcare). Image was
obtained using blue ﬂuorescent mode on Storm-840 Phos-
phorimager (GE Healthcare).
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